Ionis Pharmaceuticals Inc (IONS)

neg -5.00
Today's Range: 53.11 - 55.84 | IONS Avg Daily Volume: 1,149,800
Last Update: 09/20/17 - 12:46 PM EDT
Volume: 2,813,796
YTD Performance: 24.55%
Open: $54.20
Previous Close: $59.07
52 Week Range: $19.59 - $65.34
Oustanding Shares: 124,354,692
Market Cap: 7,407,809,002
6-Month Chart
TheStreet Ratings Grade for IONS
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 4 4 2 2
Moderate Buy 0 0 0 1
Hold 7 7 7 7
Moderate Sell 1 1 1 1
Strong Sell 0 0 0 0
Mean Rec. 2.42 2.42 2.70 2.64
Latest Dividend: 0.00
Latest Dividend Yield: 0.00%
Dividend Ex-Date: 12/31/69
Price Earnings Ratio: 283.67
Price Earnings Comparisons:
IONS Sector Avg. S&P 500
283.67 283.70 36.80
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
19.91% 86.05% 42.24%
Revenue 22.20 1.40 0.33
Net Income 0.00 0.40 0.00
EPS 0.00 0.30 0.00
Earnings for IONS:
Revenue 0.35B
Average Earnings Estimates
Qtr (09/17) Qtr (12/17) FY (12/17) FY (12/18)
Average Estimate $0.02 $-0.13 $-0.17 $-0.29
Number of Analysts 7 6 7 7
High Estimate $0.33 $0.17 $0.20 $2.49
Low Estimate $-0.21 $-0.38 $-0.46 $-1.42
Prior Year $0.06 $0.21 $-0.72 $-0.17
Growth Rate (Year over Year) -69.05% -159.52% 76.79% -72.65%
Chart Benchmark
Average Frequency Timeframe
Indicator Chart Scale  
Symbol Comparison Bollinger Bands
Aggressive traders could go long here.
These stocks are showing signs of changing direction.
Mar 10, 2017 | 6:49 AM EST
IONS was downgraded from Neutral to Sell, Goldman Sachs said. $25 price target. Question market viability of two products in Phase 3 tr...
As we await the jobs report, there is significant news across the biotech sector in the past 24 hours on some names I have mentioned in these pages.
What stocks have changed direction in the past week.
Oct 06, 2016 | 7:17 AM EDT
IONS was upgraded from Market Perform to Outperform, BMO Capital said. $48 price target. Company should benefit from pain at competitor...
With enough of earnings season now under our belt, we check out the promising themes and the sectors to avoid.
As crude oil falls below $40, stocks tied to oil are reeling.
Lots of energy names facing the potential for lower prices.
That may be the best way to get through the notorious month of August.

Columnist Conversations

The symmetry is holding up in MCD.  Target 1 is 163.34 if we continue to hold above here!  ...
As far as TSLA is concerned, I still have a higher target above the market at the 409 area.  I stated in ...
The TLT setup discussed in my last commentary is a bust. Key support was violated and it violated the recent l...
BBY is getting smoked this mornings(weak forecast).  The stock is off 8% after opening the session with a...


News Breaks

Powered by


Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.